Old Web
English
Sign In
Acemap
>
authorDetail
>
Robert D. Johnson
Robert D. Johnson
University of Texas at Austin
Pemetrexed
Pathology
Medicine
Pharmacokinetics
Carboplatin
2
Papers
231
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function
2006
Journal of Clinical Oncology
Alain C. Mita
Christopher Sweeney
Sharyn D. Baker
Andrew Goetz
Lisa A. Hammond
Amita Patnaik
Anthony W. Tolcher
Miguel A. Villalona-Calero
Alan Sandler
Tuhin K. Chaudhuri
Kathleen Molpus
Jane E. Latz
Lorinda Simms
Ajai K. Chaudhary
Robert D. Johnson
E. K. Rowinsky
Chris H. Takimoto
Show All
Source
Cite
Save
Citations (84)
Phase I Clinical and Pharmacokinetic Study of Pemetrexed and Carboplatin in Patients With Malignant Pleural Mesothelioma
2002
Journal of Clinical Oncology
A. Hughes
Paula Calvert
Ashraf Azzabi
Ruth Plummer
Robert D. Johnson
Jim Rusthoven
Melanie J. Griffin
K Fishwick
Alan V. Boddy
Mark Verrill
Hilary Calvert
Show All
Source
Cite
Save
Citations (147)
1